Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IS04 - Symposium by Bristol-Myers Squibb: Point/Counterpoint: Maximizing the Impact of I-O Across NSCLC (Not IASLC CME Accredited)
- 14:30 - 16:00
- 9/07/2019
- Location: Vancouver (2003)
- Type: Industry Symposia & Workshops
- Track:
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-09 - Predictive Clinical and Molecular Features of Long-Term Survivors Receiving Immune Checkpoint Inhibitors for Stage 4 Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Aaron John Franke | Author(s): Scott J. Antonia, Eric B Haura, Alberto Chiappori, Tawee Tanvetyanon, Jhanelle Elaine Gray, Ben Creelan
- Abstract
Loading...
-
+
MS09 - Immunotherapy in Small Cell Lung Cancer
- 14:00 - 15:30
- 9/09/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Small Cell Lung Cancer/NET
- Moderators:Alejandro Navarro, Edurne Arriola
-
+
MS09.01 - Immune Checkpoint Blockade for SCLC: State of the Art
14:00 - 14:20 | Presenter: Scott J. Antonia
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-06 - Phase I Study of Nivolumab and Ipilimumab Combined with Nintedanib in Advanced Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Jhanelle Elaine Gray | Author(s): Sonam Puri, Noemi E Rodriguez Guadalupe, Sandrine Niyongere, Theresa A Boyle, Ram Thapa, Dung-Tsa Chen, David Noyes, Monica S Chatwal, Scott J. Antonia
- Abstract
Loading...
-
+
OA14 - Update of Phase 3 Trials and the Role of HPD
- 11:30 - 13:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Oral Session
- Track: Immuno-oncology
- Moderators:Julie R Brahmer, Diego Signorelli
-
+
OA14.04 - Five-Year Outcomes From the Randomized, Phase 3 Trials CheckMate 017/057: Nivolumab vs Docetaxel in Previously Treated NSCLC
12:00 - 12:10 | Presenter: Scott Gettinger | Author(s): Hossein Borghaei, Julie R Brahmer, Laura QM Chow, Marco Angelo Burgio, Javier De Castro Carpeno, Adam Pluzanski, Oscar Arrieta, Osvaldo Aren Frontera, Rita Chiari, Charles A Butts, Joanna Wojcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip, Miriam Alonso Garcia, David M Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott J. Antonia, Markus Wohlleber, David E. Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Ernst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Everett E. Vokes
- Abstract
Loading...